Table 1 Demographic and baseline clinical characteristics
Parameter | Group A | Group B | Total |
|---|---|---|---|
Age (years) | |||
Mean (SD) | 44.5 (11.0) | 43.1(10.7) | 43.7 (10.7) |
Median | 46 | 42 | 43.5 |
Min/max | 21/66 | 26/69 | 21/69 |
Female, N (%) | 22 (68.8 %) | 23 (63.8 %) | 46 (66.2 %) |
Weight (kg) | |||
Mean (SD) | 64.7 (6.9) | 65.8 (7.8) | 65.3 (7.3) |
Median | 65 | 65.5 | 65.5 |
Min/max | 49/80 | 51/81 | 49/81 |
CD duration (years) | |||
Mean (SD) | 6.0 (2.5) | 5.8 (2.0) | 6.0 (2.2) |
Median | 6 | 6 | 6 |
Min/max | 1/12 | 1/9.5 | 1/12 |
TSUI scale | |||
Mean (SD) | 12.6 (2.9) | 13.7 (3.0) | 13.2 (3.0) |
Median | 12 | 13.5 | 13 |
Min/max | 9/19 | 9/19 | 9/19 |
HADS-anxiety | |||
Mean (SD) | 7.9 (4.2) | 7.6 (4.4) | 7.7 (4.3) |
Median | 8 | 6.5 | 8 |
Min/max | 0/17 | 0/16 | 0/17 |
HADS-depression | |||
Mean (SD) | 8.3 (3.7) | 8.5 (3.9) | 8.5 (3.8) |
Median | 9 | 8.5 | 9 |
Min/max | 0/13 | 2/17 | 0/17 |
OnabotulinumtoxinA dose | |||
Mean (SD) | 247.2 (35.1) | 257.4 (40.1) | 252.6 (37.9) |
Median | 250 | 265 | 257.5 |
Min/max | 165/300 | 150/320 | 150/320 |